Abbonarsi

Association between asthma and rhinitis according to atopic sensitization in a population-based study - 24/08/11

Doi : 10.1016/j.jaci.2003.10.010 
Bénédicte Leynaert, PhD a, , Catherine Neukirch, MD a, Sabine Kony, PhD a, Armelle Guénégou, MSc a, Jean Bousquet, MD, PhD b, Michel Aubier, MD, PhD a, Françoise Neukirch, MD a

on behalf of the European Community Respiratory Health Survey

a Inserm Unité 408, Paris, France 
b Inserm Unité 454, Montpellier, France 

Reprint requests: Bénédicte Leynaert, Inserm Unité 408, Epidémiologie Faculté de Médecine X. Bichat, BP 416-75870, Paris Cedex 18, France

Abstract

Background

Although asthma and rhinitis often occur together, the reason for this common comorbidity is still a matter of debate.

Objective

We sought to assess whether the coexistence of asthma and rhinitis could be explained by common risk factors.

Methods

International cross-sectional study of representative samples of young adults, who completed a detailed questionnaire and underwent lung function tests, bronchoprovocation challenge, IgE measurements, and skin prick tests.

Results

In all countries, asthma and bronchial hyperreactivity were more frequent in subjects with rhinitis than in those without (odds ratio [OR], 6.63; 95% CI, 5.44-8.08; and OR, 3.02 95% CI, 2.66-3.43, respectively). Seventy-four percent to 81% of subjects with asthma reported rhinitis, depending on sensitization to specific allergens. Conversely, the risk of asthma increased from 2.0% in subjects without rhinitis to 6.7% in subjects with rhinitis only when exposed to pollen, 11.9% in subjects with rhinitis when exposed to animals, and 18.8% in subjects with rhinitis either when exposed to pollen or to animals. The association between rhinitis and asthma remained significant after adjustment for total IgE, parental history of asthma, and allergen sensitization (OR, 3.41; 95% CI, 2.75-4.2 suggesting that the coexistence of asthma and rhinitis is not solely due to atopic predisposition to these 2 diseases.

Conclusions

Although there were some variations in the association between asthma and rhinitis according to sensitization to individual allergens, the strong association between asthma and rhinitis was not fully explained by shared risk factors, including atopy. Our findings are consistent with the hypothesis that rhinitis might increase the risk of asthma.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Epidemiology, rhinitis, asthma, pollen, allergens, hypersensitivity, bronchial hyperreactivity

Abbreviations : BHR, ECRHS, OR


Mappa


 The following grants helped to fund the local studies: Australia: Allen and Hanbury's, Australia. Belgium: Belgian Science Policy Office, National Fund for Scientific Research. France: Ministère de la Santé, Glaxo France, Institut Pneumologique d'Aquitaine, Contrat de Plan Etat-Région Languedoc-Roussillon, CNMATS, CNMRT (90MR/10, 91AF/6), Ministre délégué de la santé, RNSP. Germany: GSF, and the Bundesminister für Forschung und Technologie, Bonn. Greece: The Greek Secretary General of Research and Technology, Fisons, Astra, and Boehringer-Ingelheim. India: Bombay Hospital Trust. Italy: Ministero dell'Univesitàe della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93. New Zealand: Asthma Foundation of New Zealand, Lotteries Grant Board, Health Research Council of New Zealand. Norway: Norwegian Research Council project no. 101422/310. Portugal: Glaxo Farmacêutica Lda, Sandoz Portugesa. Spain: Ministero Sanidad y Consumo FIS (grants #91/0016060/OOE-05E., #92/0319, #93/0393), Hospital General de Albacete, Hospital General Juan Ramón Jiménenz, Consejeria de Sanidad Principado de Asturias. Sweden: The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy, The Swedish Society of Medicine, Astra, Glaxo-Wellcome, Boehringer-Ingelheim. Switzerland: Swiss National Science Foundation grant 4026-28099. United Kingdom: National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority. United States: United States Department of Health, Education and Welfare Public Health Service Grant #2 S07 RR05521-28.
Special thanks to UCB-Pharma-France for their financial support for this analysis.


© 2004  American Academy of Allergy, Asthma and Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 113 - N° 1

P. 86-93 - gennaio 2004 Ritorno al numero
Articolo precedente Articolo precedente
  • On the move?
| Articolo seguente Articolo seguente
  • Difficult asthma in children : An analysis of airway inflammation
  • Jacques de Blic, Isabelle Tillie-Leblond, André Bernard Tonnel, Francis Jaubert, Pierre Scheinmann, Philippe Gosset

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.